NDC 0002-8228

LYUMJEV KwikPen

Insulin Lispro-aabc

LYUMJEV KwikPen is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Insulin Lispro.

Product ID0002-8228_19854b4d-3151-4f4e-9d8d-06370db32b50
NDC0002-8228
Product TypeHuman Prescription Drug
Proprietary NameLYUMJEV KwikPen
Generic NameInsulin Lispro-aabc
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2020-06-15
Marketing CategoryBLA / BLA
Application NumberBLA761109
Labeler NameEli Lilly and Company
Substance NameINSULIN LISPRO
Active Ingredient Strength200 [iU]/mL
Pharm ClassesInsulin [Chemical/Ingredient],Insulin Analog [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0002-8228-27

2 SYRINGE in 1 CARTON (0002-8228-27) > 3 mL in 1 SYRINGE (0002-8228-01)
Marketing Start Date2020-06-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "LYUMJEV KwikPen" or generic name "Insulin Lispro-aabc"

NDCBrand NameGeneric Name
0002-7726LYUMJEVInsulin lispro-aabc
0002-7728LYUMJEVInsulin lispro-aabc
0002-8207LYUMJEVInsulin lispro-aabc
0002-8228LYUMJEVInsulin lispro-aabc
0002-8235LYUMJEVInsulin lispro-aabc
0002-8351LYUMJEVInsulin lispro-aabc

Trademark Results [LYUMJEV]

Mark Image

Registration | Serial
Company
Trademark
Application Date
LYUMJEV
LYUMJEV
97505486 not registered Live/Pending
Eli Lilly and Company
2022-07-15
LYUMJEV
LYUMJEV
88836305 not registered Live/Pending
Eli Lilly and Company
2020-03-16
LYUMJEV
LYUMJEV
88024654 not registered Live/Pending
Eli Lilly and Company
2018-07-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.